Romano, C., Ferrau’, V., Cavataio, F., Iacono, G., Spina, M., Lionetti, E., Comisi, F., Famiani, A., & Comito, D. (2014). lactobacillus reuteri in children with functional abdominal pain (FAP). Journal of Paediatrics and Child Health, 50(10). https://doi.org/10.1111/j.1440-1754.2010.01797.x
56 children (aged 6-16) with FAP
2 x 10⁸ CFU/ day of L. reuteri Protectis or placebo for 4 weeks followed by a 4-week follow-up without supplementation
Result: significant pain reduction intensity from week 0 to week 8 in the L. reuteri Protectis (n=26)
Weizman, Z., Abu-Abed, J., & Binsztok, M. (2016). Lactobacillus reuteri DSM 17938 for the management of functional abdominal pain in childhood: A randomized, double-blind, placebo-controlled trial. The Journal of Pediatrics, 174. https://doi.org/10.1016/j.jpeds.2016.04.003
93 children (average age 11-12) with at least one episode of abdominal pain per week
10⁸ CFU/ day L. reuteri Protectis or placebo for 4 weeks followed by a 4 week follow-up without supplementation
Result: Insignificant reduction in pain intensity week 0 to week 8 in the L. reuteri Protectis (n=47)
Result: insignificant reduction of number of pain episodes from week 0 to week 8 in the L. reuteri Protectis (n=47)
Jadrešin, O., Hojsak, I., Mišak, Z., Kekez, A. J., Trbojević, T., Ivković, L., & Kolaček, S. (2017). Lactobacillus reuteri DSM 17938 in the treatment of functional abdominal pain in children: RCT Study. Journal of Pediatric Gastroenterology & Nutrition, 64(6), 925–929. https://doi.org/10.1097/mpg.0000000000001478
55 children aged 4-18 with FAP or IBS
10⁸ CFU/ day L. reuteri Protectis or placebo for 12 weeks followed by a 4-week follow-up without supplementation
Result: 80% pain-free days in the L. reuteri group (n= 26)
Result: Significant reduction in severity of pain during the follow-up month (n=26)